Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.

Bronchopulmonary dysplasia (BPD) is a chronic lung injury characterized by impaired alveologenesis that may persist into adulthood. Rat models of BPD using varying degrees of hyperoxia to produce injury either cause early mortality or spontaneously recover following removal of the inciting stimulus, thus limiting clinical relevance. We sought to refine an established rat model induced by exposure to 60% O2 from birth by following hyperoxia with intermittent hypoxia (IH). Rats exposed from birth to air or 60% O2 until day 14 were recovered in air with or without IH (FIO2 = 0.10 for 10 min every 6 h) until day 28 Animals exposed to 60% O2 and recovered in air had no evidence of abnormal lung morphology on day 28 or at 10-12 wk. In contrast, 60% O2-exposed animals recovered in IH had persistently increased mean chord length, more dysmorphic septal crests, and fewer peripheral arteries. Recovery in IH also increased pulmonary vascular resistance, Fulton index, and arterial wall thickness. IH-mediated abnormalities in lung structure (but not pulmonary hypertension) persisted when reexamined at 10-12 wk, accompanied by increased pulmonary vascular reactivity and decreased exercise tolerance. Increased mean chord length secondary to IH was prevented by treatment with a peroxynitrite decomposition catalyst [5,10,15,20-Tetrakis(4-sulfonatophenyl)-21H,23H-porphyrin iron (III) chloride, 30 mg/kg/day, days 14-28], an effect accompanied by fewer inflammatory cells. We conclude that IH during recovery from hyperoxia-induced injury prevents recovery of alveologenesis and leads to changes in lung and pulmonary vascular function lasting into adulthood, thus more closely mimicking contemporary BPD.

[1]  Amish Jain,et al.  Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[2]  S. Wedgwood,et al.  Postnatal growth restriction augments oxygen-induced pulmonary hypertension in a neonatal rat model of bronchopulmonary dysplasia , 2016, Pediatric Research.

[3]  N. Ambalavanan,et al.  Searching for better animal models of BPD: a perspective. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[4]  Amish Jain,et al.  Leukotriene B4 mediates macrophage influx and pulmonary hypertension in bleomycin-induced chronic neonatal lung injury. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[5]  H. Nakanishi,et al.  Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study , 2016, Journal of Perinatology.

[6]  S. Meiners,et al.  Early injury of the neonatal lung contributes to premature lung aging: a hypothesis , 2016, Molecular and Cellular Pediatrics.

[7]  A. Benedetti,et al.  Lung Function and Bronchial Hyperresponsiveness in Adults Born Prematurely. A Cohort Study. , 2016, Annals of the American Thoracic Society.

[8]  L. Nielsen,et al.  Effects of intermittent hypoxia and hyperoxia on angiogenesis and lung development in newborn mice. , 2016, Journal of neonatal-perinatal medicine.

[9]  M. Walsh,et al.  Hypoxic Episodes in Bronchopulmonary Dysplasia. , 2015, Clinics in perinatology.

[10]  Diogo M Silva,et al.  Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[11]  A. Tanswell,et al.  Neutrophil elastase-induced elastin degradation mediates macrophage influx and lung injury in 60% O2-exposed neonatal rats. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[12]  G. Eide,et al.  Adult respiratory outcomes of extreme preterm birth. A regional cohort study. , 2015, Annals of the American Thoracic Society.

[13]  A. Tanswell,et al.  Chronic lung injury in the neonatal rat: up-regulation of TGFβ1 and nitration of IGF-R1 by peroxynitrite as likely contributors to impaired alveologenesis. , 2015, Free radical biology & medicine.

[14]  B. Thébaud,et al.  Translational Research in Acute Lung Injury and Pulmonary Fibrosis Animal models of bronchopulmonary dysplasia . The term rat models , 2014 .

[15]  A. Tanswell,et al.  Cyclooxygenase‐2 inhibition partially protects against 60% O2‐mediated lung injury in neonatal rats , 2014, Pediatric pulmonology.

[16]  A. Fraser,et al.  Cardiovascular function in children who had chronic lung disease of prematurity , 2014, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[17]  B. Schmidt,et al.  Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. , 2014, Annals of the American Thoracic Society.

[18]  P. McNamara,et al.  Therapeutic hypercapnia prevents inhaled nitric oxide-induced right-ventricular systolic dysfunction in juvenile rats. , 2014, Free radical biology & medicine.

[19]  A. Cartón,et al.  Pulmonary hypertension in bronchopulmonary dysplasia: Clinical findings, cardiovascular anomalies and outcomes , 2014, Pediatric pulmonology.

[20]  O. Eickelberg,et al.  Chronic lung disease in the preterm infant. Lessons learned from animal models. , 2013, American journal of respiratory cell and molecular biology.

[21]  P. McNamara,et al.  Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation. , 2013, American journal of respiratory cell and molecular biology.

[22]  W. Carlo,et al.  Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants , 2012, Pediatrics.

[23]  A. Tanswell,et al.  A peroxynitrite decomposition catalyst prevents 60% O2-mediated rat chronic neonatal lung injury. , 2010, Free radical biology & medicine.

[24]  E. Bae,et al.  Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia , 2010, Korean circulation journal.

[25]  Matthias Ochs,et al.  Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. , 2010, Journal of applied physiology.

[26]  Kurt R Stenmark,et al.  Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[27]  P. McNamara,et al.  Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[28]  A. Tanswell,et al.  A Critical Role for the IL-1 Receptor in Lung Injury Induced in Neonatal Rats by 60% O2 , 2009, Pediatric Research.

[29]  Marcus H. Jones,et al.  Growth of the lung parenchyma early in life. , 2009, American journal of respiratory and critical care medicine.

[30]  J. Aschner,et al.  Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[31]  N. French,et al.  Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia , 2008, European Respiratory Journal.

[32]  W. Truog,et al.  Pulmonary Nitric Oxide Synthases and Nitrotyrosine: Findings During Lung Development and in Chronic Lung Disease of Prematurity , 2006, Pediatrics.

[33]  L. Doyle,et al.  Neurodevelopmental outcome of bronchopulmonary dysplasia. , 2006, Seminars in perinatology.

[34]  P. McNamara,et al.  Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[35]  A. Halayko,et al.  Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[36]  A. Tanswell,et al.  Hepatocyte growth factor is required for alveologenesis in the neonatal rat. , 2005, American journal of respiratory and critical care medicine.

[37]  W. Truog,et al.  Acinar arterial changes with chronic lung disease of prematurity in the surfactant era , 2003, Pediatric pulmonology.

[38]  J. Coalson Pathology of new bronchopulmonary dysplasia. , 2003, Seminars in neonatology : SN.

[39]  A. Delabays,et al.  Augmented vasoreactivity in adult life associated with perinatal vascular insult , 1999, The Lancet.

[40]  H. Ischiropoulos,et al.  Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. , 1998, Pediatrics.

[41]  Jeffrey F. Young,et al.  Changes in Structure, Mechanics, and Insulin-Like Growth Factor-Related Gene Expression in the Lungs of Newborn Rats Exposed to Air or 60% Oxygen , 1996, Pediatric Research.

[42]  W. Carlo,et al.  Oxygen desaturation complicates feeding in infants with bronchopulmonary dysplasia after discharge. , 1992, Pediatrics.

[43]  T. Keens,et al.  Clinically unsuspected hypoxia during sleep and feeding in infants with bronchopulmonary dysplasia. , 1988, Pediatrics.

[44]  N. G. Ghoshal,et al.  Morphology of the terminal bronchiolar region of common laboratory mammals , 1988, Laboratory animals.

[45]  R. Hubbard,et al.  Effect of age, weight, and metabolic rate on endurance, hyperthermia, and heatstroke mortality in a small animal model. , 1986, Aviation, space, and environmental medicine.

[46]  L. Frank,et al.  Oxygen toxicity in newborn rats: the adverse effects of undernutrition. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[47]  Z. Kun The variation of residual impurities in ZnSe crystals used in light‐emitting diode fabrications , 1982 .

[48]  C. Carrington,et al.  Morphometry of the Human Lung , 1965, The Yale Journal of Biology and Medicine.